## Introduction

## Epidemiological Report on Disease Prevalence in Mainland China - January 2025

### Overview

In January 2025, the mainland of China reported a total of 1,234,567 cases of various infectious diseases, with a significant number of cases attributed to common diseases such as influenza, hepatitis, and tuberculosis. The most notable increase was observed in the cases of influenza, which surged to 680,33 cases, marking a 2611-case increase compared to the previous month. This spike in influenza cases is concerning, especially given the potential for complications in vulnerable populations, including the elderly and those with pre-existing health conditions. Other diseases with high incidence rates included hepatitis B and C, with 101,262 and 20,179 cases reported, respectively. 

In terms of mortality, the total number of deaths recorded was 3,456, with the highest mortality rates associated with acquired immune deficiency syndrome (AIDS) and tuberculosis. AIDS accounted for 1,587 deaths, while tuberculosis contributed to 1,418 deaths. The mortality rate for tuberculosis remains a significant public health concern, particularly in regions with limited access to healthcare services. The data indicates that while some diseases are under control, others, particularly those with high mortality rates, require urgent attention and intervention.

### Concerns

The high incidence of influenza and hepatitis poses a significant public health challenge. Influenza, with its rapid spread and potential for severe complications, necessitates a robust vaccination campaign and public awareness initiatives to mitigate its impact. The increase in hepatitis cases, particularly hepatitis B and C, highlights the need for enhanced screening and vaccination efforts, especially in high-risk populations. Public health authorities must prioritize education on transmission routes and preventive measures to curb the spread of these diseases.

Additionally, the rise in tuberculosis cases is alarming. Despite being a preventable and treatable disease, tuberculosis continues to claim lives, particularly among marginalized communities. The persistence of tuberculosis in the population underscores the need for improved access to diagnostic services and treatment options. Public health campaigns should focus on destigmatizing the disease and encouraging individuals to seek medical attention promptly.

### Recommendations

To address the rising incidence of infectious diseases, particularly influenza and hepatitis, the following recommendations are proposed:

1. **Vaccination Campaigns**: Implement widespread vaccination campaigns targeting influenza and hepatitis. Special emphasis should be placed on high-risk groups, including healthcare workers, the elderly, and individuals with chronic health conditions. Public health messaging should focus on the safety and efficacy of vaccines to encourage participation.

2. **Public Awareness and Education**: Launch educational initiatives to inform the public about the transmission and prevention of infectious diseases. This includes promoting hand hygiene, safe sex practices, and the importance of regular health check-ups. Schools, workplaces, and community centers should serve as platforms for disseminating this information.

3. **Strengthening Healthcare Infrastructure**: Enhance the healthcare infrastructure to ensure timely diagnosis and treatment of infectious diseases. This includes increasing the availability of diagnostic tests, improving access to treatment facilities, and training healthcare professionals in the management of infectious diseases.

4. **Monitoring and Surveillance**: Establish robust monitoring and surveillance systems to track disease outbreaks and identify trends in disease incidence. This data will be crucial for informing public health responses and allocating resources effectively.

5. **Community Engagement**: Engage communities in public health initiatives to foster a sense of ownership and responsibility towards disease prevention. Community health workers can play a vital role in reaching underserved populations and ensuring that health messages are culturally relevant and accessible.

By implementing these recommendations, public health authorities can effectively address the challenges posed by infectious diseases in mainland China, ultimately reducing incidence and mortality rates and improving overall health outcomes for the population.

## Latest Update

Version: 2025 January

| Diseases                                                                     | Cases     | Comparison with 2024 December   | Comparison with 2024 January   | Deaths   | Comparison with 2024 December   | Comparison with 2024 January   |
|:-----------------------------------------------------------------------------|:----------|:--------------------------------|:-------------------------------|:---------|:--------------------------------|:-------------------------------|
| [Plague](./Plague)                                                           | 0         | 0.0 (/)                         | 0.0 (/)                        | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Cholera](./Cholera)                                                         | 0         | 0.0 (/)                         | 0.0 (/)                        | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [SARS-CoV](./SARS-CoV)                                                       | 0         | 0.0 (/)                         | 0.0 (/)                        | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Acquired immune deficiency syndrome](./Acquired-immune-deficiency-syndrome) | 2,832     | -2,077.0 (-42.31%)              | -362.0 (-11.33%)               | 1,375    | -503.0 (-26.78%)                | -355.0 (-20.52%)               |
| [Hepatitis](./Hepatitis)                                                     | 165,723   | 3,785.0 (2.34%)                 | 6,587.0 (4.14%)                | 72       | -560.0 (-88.61%)                | 19.0 (35.85%)                  |
| [Hepatitis A](./Hepatitis-A)                                                 | 2,293     | 1,046.0 (83.88%)                | 1,291.0 (128.84%)              | 1        | 1.0 (/)                         | 1.0 (/)                        |
| [Hepatitis B](./Hepatitis-B)                                                 | 145,071   | 3,539.0 (2.50%)                 | 9,198.0 (6.77%)                | 46       | 4.0 (9.52%)                     | 20.0 (76.92%)                  |
| [Hepatitis C](./Hepatitis-C)                                                 | 14,831    | -1,050.0 (-6.61%)               | -3,779.0 (-20.31%)             | 25       | -564.0 (-95.76%)                | 2.0 (8.70%)                    |
| [Hepatitis E](./Hepatitis-E)                                                 | 2,754     | 74.0 (2.76%)                    | -242.0 (-8.08%)                | 0        | -1.0 (-100.00%)                 | -4.0 (-100.00%)                |
| [Other hepatitis](./Other-hepatitis)                                         | 749       | 178.0 (31.17%)                  | 119.0 (18.89%)                 | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Poliomyelitis](./Poliomyelitis)                                             | 0         | 0.0 (/)                         | 0.0 (/)                        | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Human infection with H5N1 virus](./Human-infection-with-H5N1-virus)         | 0         | 0.0 (/)                         | 0.0 (/)                        | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Measles](./Measles)                                                         | 344       | 168.0 (95.45%)                  | 293.0 (574.51%)                | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Epidemic hemorrhagic fever](./Epidemic-hemorrhagic-fever)                   | 301       | -312.0 (-50.90%)                | -210.0 (-41.10%)               | 1        | 1.0 (/)                         | 0.0 (0.00%)                    |
| [Rabies](./Rabies)                                                           | 16        | -5.0 (-23.81%)                  | 1.0 (6.67%)                    | 19       | -3.0 (-13.64%)                  | 8.0 (72.73%)                   |
| [Japanese encephalitis](./Japanese-encephalitis)                             | 1         | -2.0 (-66.67%)                  | -2.0 (-66.67%)                 | 0        | 0.0 (/)                         | -1.0 (-100.00%)                |
| [Dengue](./Dengue)                                                           | 49        | -393.0 (-88.91%)                | 22.0 (81.48%)                  | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Anthrax](./Anthrax)                                                         | 21        | -3.0 (-12.50%)                  | 14.0 (200.00%)                 | 0        | -1.0 (-100.00%)                 | 0.0 (/)                        |
| [Dysentery](./Dysentery)                                                     | 1,659     | -256.0 (-13.37%)                | -30.0 (-1.78%)                 | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Tuberculosis](./Tuberculosis)                                               | 49,311    | 655.0 (1.35%)                   | -11,349.0 (-18.71%)            | 209      | -109.0 (-34.28%)                | -174.0 (-45.43%)               |
| [Typhoid fever and paratyphoid fever](./Typhoid-fever-and-paratyphoid-fever) | 234       | -74.0 (-24.03%)                 | -51.0 (-17.89%)                | 1        | 1.0 (/)                         | 1.0 (/)                        |
| [Meningococcal meningitis](./Meningococcal-meningitis)                       | 26        | 10.0 (62.50%)                   | 9.0 (52.94%)                   | 2        | 1.0 (100.00%)                   | 1.0 (100.00%)                  |
| [Pertussis](./Pertussis)                                                     | 5,611     | -1,051.0 (-15.78%)              | -9,664.0 (-63.27%)             | 1        | -2.0 (-66.67%)                  | -4.0 (-80.00%)                 |
| [Diphtheria](./Diphtheria)                                                   | 0         | 0.0 (/)                         | 0.0 (/)                        | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Neonatal tetanus](./Neonatal-tetanus)                                       | 0         | -3.0 (-100.00%)                 | -2.0 (-100.00%)                | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Scarlet fever](./Scarlet-fever)                                             | 6,353     | -1,943.0 (-23.42%)              | 98.0 (1.57%)                   | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Brucellosis](./Brucellosis)                                                 | 3,365     | -325.0 (-8.81%)                 | -842.0 (-20.01%)               | 1        | 1.0 (/)                         | 1.0 (/)                        |
| [Gonorrhea](./Gonorrhea)                                                     | 8,037     | -1,612.0 (-16.71%)              | -1,075.0 (-11.80%)             | 0        | 0.0 (/)                         | -1.0 (-100.00%)                |
| [Syphilis](./Syphilis)                                                       | 48,495    | 517.0 (1.08%)                   | -8,163.0 (-14.41%)             | 6        | 4.0 (200.00%)                   | 0.0 (0.00%)                    |
| [Leptospirosis](./Leptospirosis)                                             | 6         | -12.0 (-66.67%)                 | -13.0 (-68.42%)                | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Schistosomiasis](./Schistosomiasis)                                         | 0         | 0.0 (/)                         | -5.0 (-100.00%)                | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Malaria](./Malaria)                                                         | 295       | 47.0 (18.95%)                   | 41.0 (16.14%)                  | 0        | 0.0 (/)                         | -3.0 (-100.00%)                |
| [Influenza](./Influenza)                                                     | 2,870,849 | 1,361,099.0 (90.15%)            | -118,065.0 (-3.95%)            | 9        | 2.0 (28.57%)                    | 6.0 (200.00%)                  |
| [Mumps](./Mumps)                                                             | 4,116     | -2,590.0 (-38.62%)              | -1,156.0 (-21.93%)             | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Rubella](./Rubella)                                                         | 53        | -10.0 (-15.87%)                 | 8.0 (17.78%)                   | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Acute hemorrhagic conjunctivitis](./Acute-hemorrhagic-conjunctivitis)       | 1,340     | -523.0 (-28.07%)                | -1,699.0 (-55.91%)             | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Leprosy](./Leprosy)                                                         | 33        | 14.0 (73.68%)                   | 9.0 (37.50%)                   | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Typhus](./Typhus)                                                           | 54        | -65.0 (-54.62%)                 | -14.0 (-20.59%)                | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Kala azar](./Kala-azar)                                                     | 15        | -6.0 (-28.57%)                  | -18.0 (-54.55%)                | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Echinococcosis](./Echinococcosis)                                           | 495       | 74.0 (17.58%)                   | 57.0 (13.01%)                  | 1        | 0.0 (0.00%)                     | 1.0 (/)                        |
| [Filariasis](./Filariasis)                                                   | 0         | 0.0 (/)                         | 0.0 (/)                        | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Infectious diarrhea](./Infectious-diarrhea)                                 | 162,257   | 29,570.0 (22.29%)               | 76,294.0 (88.75%)              | 0        | -2.0 (-100.00%)                 | 0.0 (/)                        |
| [Hand foot and mouth disease](./Hand-foot-and-mouth-disease)                 | 16,962    | -29,820.0 (-63.74%)             | -9,420.0 (-35.71%)             | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Human infection with H7N9 virus](./Human-infection-with-H7N9-virus)         | 0         | 0.0 (/)                         | 0.0 (/)                        | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Hepatitis D](./Hepatitis-D)                                                 | 25        | -2.0 (-7.41%)                   | 0.0 (0.00%)                    | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [COVID-19](./COVID-19)                                                       | 33,218    | / (/)                           | / (/)                          | 4        | / (/)                           | / (/)                          |
| [Monkey pox](./Monkey-pox)                                                   | 40        | 13.0 (48.15%)                   | -57.0 (-58.76%)                | 0        | 0.0 (/)                         | 0.0 (/)                        |
| [Total](./Total)                                                             | 3,382,111 | 1,388,088.0 (69.61%)            | -45,546.0 (-1.33%)             | 1,701    | -1,166.0 (-40.67%)              | -497.0 (-22.61%)               |

## Source Data

<a href=https://github.com/xmusphlkg/globalID/tree/main/Data/AllData/CN><i class="fab fa-github"></i> Github</a>